Report Detail

Other Global Major Depressive Disorder Market Size, Status and Forecast 2019-2025

  • RnM3462721
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 96 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Major Depressive Disorder Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Drugs Therapy
      • 1.4.3 Biological Therapy
      • 1.4.4 Meditation
      • 1.4.5 Physiotherapy
      • 1.4.6 Other
    • 1.5 Market by Application
      • 1.5.1 Global Major Depressive Disorder Market Share by Application (2014-2025)
      • 1.5.2 Under 25 Years Old
      • 1.5.3 25-45 Years Old
      • 1.5.4 Above 45 Years Old
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Major Depressive Disorder Market Size
    • 2.2 Major Depressive Disorder Growth Trends by Regions
      • 2.2.1 Major Depressive Disorder Market Size by Regions (2014-2025)
      • 2.2.2 Major Depressive Disorder Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Major Depressive Disorder Market Size by Manufacturers
      • 3.1.1 Global Major Depressive Disorder Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Major Depressive Disorder Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Major Depressive Disorder Market Concentration Ratio (CR5 and HHI)
    • 3.2 Major Depressive Disorder Key Players Head office and Area Served
    • 3.3 Key Players Major Depressive Disorder Product/Solution/Service
    • 3.4 Date of Enter into Major Depressive Disorder Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Major Depressive Disorder Market Size by Type (2014-2019)
    • 4.2 Global Major Depressive Disorder Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Major Depressive Disorder Market Size (2014-2019)
    • 5.2 Major Depressive Disorder Key Players in United States
    • 5.3 United States Major Depressive Disorder Market Size by Type
    • 5.4 United States Major Depressive Disorder Market Size by Application

    6 Europe

    • 6.1 Europe Major Depressive Disorder Market Size (2014-2019)
    • 6.2 Major Depressive Disorder Key Players in Europe
    • 6.3 Europe Major Depressive Disorder Market Size by Type
    • 6.4 Europe Major Depressive Disorder Market Size by Application

    7 China

    • 7.1 China Major Depressive Disorder Market Size (2014-2019)
    • 7.2 Major Depressive Disorder Key Players in China
    • 7.3 China Major Depressive Disorder Market Size by Type
    • 7.4 China Major Depressive Disorder Market Size by Application

    8 Japan

    • 8.1 Japan Major Depressive Disorder Market Size (2014-2019)
    • 8.2 Major Depressive Disorder Key Players in Japan
    • 8.3 Japan Major Depressive Disorder Market Size by Type
    • 8.4 Japan Major Depressive Disorder Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Major Depressive Disorder Market Size (2014-2019)
    • 9.2 Major Depressive Disorder Key Players in Southeast Asia
    • 9.3 Southeast Asia Major Depressive Disorder Market Size by Type
    • 9.4 Southeast Asia Major Depressive Disorder Market Size by Application

    10 India

    • 10.1 India Major Depressive Disorder Market Size (2014-2019)
    • 10.2 Major Depressive Disorder Key Players in India
    • 10.3 India Major Depressive Disorder Market Size by Type
    • 10.4 India Major Depressive Disorder Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Major Depressive Disorder Market Size (2014-2019)
    • 11.2 Major Depressive Disorder Key Players in Central & South America
    • 11.3 Central & South America Major Depressive Disorder Market Size by Type
    • 11.4 Central & South America Major Depressive Disorder Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Major Depressive Disorder Introduction
      • 12.1.4 Pfizer Revenue in Major Depressive Disorder Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Eli Lilly
      • 12.2.1 Eli Lilly Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Major Depressive Disorder Introduction
      • 12.2.4 Eli Lilly Revenue in Major Depressive Disorder Business (2014-2019)
      • 12.2.5 Eli Lilly Recent Development
    • 12.3 H. Lundbeck
      • 12.3.1 H. Lundbeck Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Major Depressive Disorder Introduction
      • 12.3.4 H. Lundbeck Revenue in Major Depressive Disorder Business (2014-2019)
      • 12.3.5 H. Lundbeck Recent Development
    • 12.4 Otsuka Pharmaceutical
      • 12.4.1 Otsuka Pharmaceutical Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Major Depressive Disorder Introduction
      • 12.4.4 Otsuka Pharmaceutical Revenue in Major Depressive Disorder Business (2014-2019)
      • 12.4.5 Otsuka Pharmaceutical Recent Development
    • 12.5 AstraZeneca
      • 12.5.1 AstraZeneca Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Major Depressive Disorder Introduction
      • 12.5.4 AstraZeneca Revenue in Major Depressive Disorder Business (2014-2019)
      • 12.5.5 AstraZeneca Recent Development
    • 12.6 Alkermes
      • 12.6.1 Alkermes Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Major Depressive Disorder Introduction
      • 12.6.4 Alkermes Revenue in Major Depressive Disorder Business (2014-2019)
      • 12.6.5 Alkermes Recent Development
    • 12.7 Takeda Pharmaceutical
      • 12.7.1 Takeda Pharmaceutical Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Major Depressive Disorder Introduction
      • 12.7.4 Takeda Pharmaceutical Revenue in Major Depressive Disorder Business (2014-2019)
      • 12.7.5 Takeda Pharmaceutical Recent Development
    • 12.8 Naurex
      • 12.8.1 Naurex Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Major Depressive Disorder Introduction
      • 12.8.4 Naurex Revenue in Major Depressive Disorder Business (2014-2019)
      • 12.8.5 Naurex Recent Development
    • 12.9 Euthymics Bioscience
      • 12.9.1 Euthymics Bioscience Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Major Depressive Disorder Introduction
      • 12.9.4 Euthymics Bioscience Revenue in Major Depressive Disorder Business (2014-2019)
      • 12.9.5 Euthymics Bioscience Recent Development
    • 12.10 E-therapeutics
      • 12.10.1 E-therapeutics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Major Depressive Disorder Introduction
      • 12.10.4 E-therapeutics Revenue in Major Depressive Disorder Business (2014-2019)
      • 12.10.5 E-therapeutics Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, and have sudden weight loss. Moreover, they can have other mental and physical symptoms such as fatigue, memory loss, feeling of hopelessness, body aches, headaches, and thoughts of suicide.
      In terms of geography, North America dominates the global major depressive disorder market due to increased awareness about various depression conditions in the region. The U.S. represents the largest market for major depressive disorder in North America, followed by Canada. In Europe, Germany, France, the U.K., Italy, and Spain account for a major share of the major depressive disorder market. This market in Asia is expected to expand at a significant rate over the next five years. This is due to various companies setting up manufacturing facilities in the region. Moreover, increasing awareness about various depression episodes and rise in geriatric population are also driving the growth of the market in the region. India, China, and Japan are expected to be the fastest growing major depressive disorder markets in Asia.
      In 2018, the global Major Depressive Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Major Depressive Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Major Depressive Disorder development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Eli Lilly
      H. Lundbeck
      Otsuka Pharmaceutical
      AstraZeneca
      Alkermes
      Takeda Pharmaceutical
      Naurex
      Euthymics Bioscience
      E-therapeutics

      Market segment by Type, the product can be split into
      Drugs Therapy
      Biological Therapy
      Meditation
      Physiotherapy
      Other

      Market segment by Application, split into
      Under 25 Years Old
      25-45 Years Old
      Above 45 Years Old

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Major Depressive Disorder status, future forecast, growth opportunity, key market and key players.
      To present the Major Depressive Disorder development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Major Depressive Disorder are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Major Depressive Disorder . Industry analysis & Market Report on Major Depressive Disorder is a syndicated market report, published as Global Major Depressive Disorder Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Major Depressive Disorder market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,081.12
      4,621.69
      6,162.25
      3,537.80
      5,306.70
      7,075.60
      423,126.60
      634,689.90
      846,253.20
      278,422.17
      417,633.26
      556,844.34
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report